
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 963 | 963 | 994 | 1160 | 1853 | 1913 |
Fund Return | -3.67% | -3.67% | -0.59% | 5.08% | 13.13% | 6.7% |
Place in category | 2960 | 2960 | 5021 | 1543 | 981 | 895 |
% in Category | 47 | 47 | 79 | 28 | 23 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 7.33B | -6.77 | 7.41 | 11.36 | ||
UBS CH Vitainvest 50 World U | 4.01B | 7.32 | -1.50 | 2.35 | ||
UBS CH Institutional Fund 2 EquiPAX | 3.89B | -4.31 | 6.73 | 9.07 | ||
UBS CH Institutional Fund 2 EquiSCA | 2.54B | 3.61 | 3.69 | 7.88 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.54B | -0.41 | 2.98 | 6.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 6.65B | 28.87 | 6.79 | - | ||
Swisscanto CH IPF I Index Equity Fu | 6.73B | 3.52 | 9.32 | 10.99 | ||
CH0337393745 | 5.63B | 27.07 | 6.15 | - | ||
Swisscanto CH IPF III Index EquAST | 5.87B | 28.59 | 6.60 | 9.22 | ||
UBS CH Institutional Fund 2 EquiPAX | 3.89B | -4.31 | 6.73 | 9.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.19 | 388.45 | +1.86% | |
Amazon.com | US0231351067 | 3.47 | 184.87 | +2.01% | |
Broadcom | US11135F1012 | 3.04 | 181.94 | +5.59% | |
Eli Lilly | US5324571083 | 2.79 | 732.41 | +1.60% | |
Take-Two | US8740541094 | 2.71 | 212.07 | +3.75% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review